Medication info
Empagrombi Tablet 5/500 mg (Empagliflozin, Metformin hydrochloride)

Empagrombi Tablet 5/500 mg (Empagliflozin, Metformin hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›5mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Aprogen Biosolutions Co., Ltd.
Appearance
Orange-yellow, biconvex oval film-coated tablet
Packaging
10 tablets/box [(10 tablets/PTP x 1)], 60 tablets/box [(10 tablets/PTP x 6)], 30 tablets/bottle, 60 tablets/bottle
Approval status
Active

MFDS item code 202201333 · Approved 2022.04.04 · Insurance code 645210980

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes
Who takes it
Adults
Adult dose
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take twice the dose at one time; in this case, skip the missed dose. Special Populations Patients with Renal Impairment No dose adjustment is required for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who have no other condition that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily, so treatment should be initiated with the individual single-ingredient products empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, discontinue this medicine immediately (see Precautions for Use, 2. Do not administer to the following patients, item 2)). Elderly Patients In patients aged 75 years or older, consider renal function and the risk of volume depletion.

Ingredients

Manufacturer
Aprogen Biosolutions Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes

  • Abnormal blood sugar control
  • type 2 diabetes
View approved original text

This medication is used as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes. It is particularly suitable for adult patients being treated with a combination of empagliflozin and metformin. Caution is needed for type 2 diabetes patients with cardiovascular disease when glycemic control is insufficient to assess the risk of cardiovascular events, and relevant clinical information should also be consulted. Overall, this medication improves blood sugar management and supports patient health care.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take twice the dose at one time; in this case, skip the missed dose. Special Populations Patients with Renal Impairment No dose adjustment is required for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who have no other condition that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily, so treatment should be initiated with the individual single-ingredient products empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, discontinue this medicine immediately (see Precautions for Use, 2. Do not administer to the following patients, item 2)). Elderly Patients In patients aged 75 years or older, consider renal function and the risk of volume depletion.

Precautions

This medication helps lower blood sugar and is used in diabetes treatment. However, it should not be used in patients with significantly impaired kidney function, acute infections, dehydration, or severe heart disease. Women who are pregnant or breastfeeding should not take this medication. During treatment, symptoms of hypoglycemia may occur, so caution is needed when using it with insulin or other hypoglycemic agents. Additionally, this medication can cause urinary or genital infections; if such symptoms occur, consult a physician immediately. It should be used cautiously in patients with poor liver or kidney function, or in situations at risk of fluid loss, and kidney function should be regularly monitored through blood tests. Temporary suspension of this medication is required before and after surgeries or tests using iodinated contrast agents, and kidney function must be confirmed before resuming treatment. This medication can lower vitamin B12 levels, so long-term users may need to check their vitamin B12 concentrations. Alcohol may increase the risk of side effects from this medication, so excessive drinking should be avoided during treatment. Furthermore, this medication can affect body fluid levels, so caution is especially necessary for the elderly or those at risk for dehydration. During the use of this medication, if symptoms such as fever, pain, swelling, or rash around the genital or perineal areas occur, healthcare providers should be informed immediately. Finally, this medication is not recommended for children under 18 years of age, and dosages for the elderly should be adjusted based on kidney function.

Side effects

  • Hypoglycemia
  • urinary tract infection
  • genital infection
  • increased urination
  • nausea
  • vomiting
  • diarrhea
  • abdominal pain
  • loss of appetite
  • constipation
Show 200 more
  • abnormal liver function tests
  • hepatitis
  • taste disturbance
  • itching
  • rash
  • hives
  • erythema
  • angioedema
  • dysuria
  • interstitial nephritis
  • thirst
  • increased serum lipids
  • increased serum creatinine
  • decreased glomerular filtration rate
  • increased hematocrit
  • ketoacidosis
  • lactic acidosis
  • decreased fluid volume
  • weight loss
  • headache
  • dizziness
  • insomnia
  • fever
  • weakness
  • chest pain
  • chest discomfort
  • ankle fracture
  • epicondylitis
  • facial bone fracture
  • musculoskeletal pain
  • cerebral infarction
  • soft tissue infection
  • pneumonia
  • vascular stent stenosis
  • vascular stent thrombosis
  • acute pyelonephritis
  • sepsis
  • subcutaneous abscess
  • tubo-ovarian abscess
  • vestibular neuritis
  • nasopharyngitis
  • upper respiratory infection
  • bronchitis
  • chronic sinusitis
  • gastroenteritis
  • Helicobacter infection
  • periodontitis
  • chronic tonsillitis
  • conjunctivitis
  • influenza
  • laryngitis
  • meningitis
  • chronic otitis media
  • paronychia
  • peritonsillar abscess
  • pulmonary tuberculosis
  • tinea versicolor
  • dental abscess
  • vestibular neuritis
  • positional vertigo
  • sensory loss
  • perceptual disturbances
  • amnesia
  • carotid stenosis
  • diabetic neuropathy
  • facial paralysis
  • intracranial aneurysm
  • memory disturbances
  • neuralgia
  • Parkinsonism
  • polyneuropathy
  • sensory impairment
  • drowsiness
  • CNS origin dizziness
  • fatigue
  • peripheral edema
  • facial edema
  • peripheral edema
  • chills
  • strange sensations
  • edema
  • pain
  • pain at the puncture site
  • increased alanine aminotransferase
  • increased aspartate aminotransferase
  • weight gain
  • abnormal ECG
  • decreased hemoglobin
  • increased hemoglobin
  • positive Helicobacter test
  • positive urine red blood cells
  • ureteral stones
  • acute kidney injury
  • chronic kidney disease
  • hematuria
  • overactive bladder
  • renal mass
  • urinary retention
  • urinary pain
  • abnormal urination
  • cervical inflammation
  • hyperglycemia
  • hyponatremia
  • dermal cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • diabetic foot
  • nummular eczema
  • prickly heat
  • sebaceous gland hyperplasia
  • lumbar spinal canal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal abrasion
  • macular fibrosis
  • ocular discomfort
  • ocular congestion
  • pathological myopia
  • retinal detachment
  • retinal deposits
  • retinal vein occlusion
  • traction retinal detachment
  • eyelid swelling
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • nasal bleeding
  • asthma
  • exertional dyspnea
  • wet cough
  • allergic rhinitis
  • residual sputum
  • cough
  • skin laceration
  • bruise
  • rib fracture
  • concussion
  • corneal abrasion
  • fall
  • hand fracture
  • iliotibial band syndrome
  • open globe injury
  • pelvic fracture
  • road traffic accident
  • splenic injury
  • sternum fracture
  • angina
  • palpitations
  • Prinzmetal angina
  • coronary artery disease
  • tachycardia
  • arteriosclerosis
  • deep vein thrombosis
  • diabetic vascular complications
  • peripheral artery occlusive disease
  • anxiety
  • depression
  • sleep disorders
  • otalgia
  • orthostatic dizziness
  • dizziness
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • diarrhea
  • dyspepsia
  • abdominal pain
  • gastritis
  • gastrointestinal disturbances
  • herpes zoster
  • cervical dysplasia
  • scrotal pain
  • sexual dysfunction
  • vaginal discharge
  • hypoglycemia
  • reduced appetite
  • obesity
  • acromegaly
  • hyperlipidemia
  • vulvar pruritus
  • genital pruritus
  • diabetic retinopathy
  • dry eyes
  • dyspnea
  • unstable angina

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or humidity and must be stored in a tightly sealed container. It is important to maintain a storage temperature between 1 and 30 degrees Celsius to preserve the drug’s efficacy.

Appearance and packaging

Appearance

Orange-yellow, biconvex oval film-coated tablet

Package unit

10 tablets/box [(10 tablets/PTP x 1)], 60 tablets/box [(10 tablets/PTP x 6)], 30 tablets/bottle, 60 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.